Highly oncolytic adherent lymphocytes: Therapeutic relevance for leukemia

This publication has 13 references indexed in Scilit:

• Biology of Natural Killer Cells
  Published by Elsevier ,2008
• Unimpaired ability to generate adherent lymphokine-activated killer (A-LAK) cells in patients with primary or metastatic liver tumors
  Cancer Immunology, Immunotherapy, 1989
• Adherent lymphokine-activated killer cells in chronic myelogenous leukemia: a benign cell population with potent cytotoxic activity
  Blood, 1989
• Lysis of CR2-carrying cells by natural killer cells and by activated T-lymphocytes is enhanced by C3 fragments
  Molecular Immunology, 1988
• Similarities between LAK cells derived from human thymocytes and peripheral blood lymphocytes: Expression of the NKH-1 and CD3 antigens
  Cellular Immunology, 1988
• Interleukin 2 induction of lymphokine-activated killer (LAK) activity in the peripheral blood and bone marrow of acute leukemia patients. I. Feasibility of LAK generation in adult patients with active disease and in remission
  Blood, 1988
• Cytolytic antitumor effector cells in long-term cultures of human tumor-infiltrating lymphocytes in recombinant interleukin 2
  Cancer Immunology, Immunotherapy, 1988
• Lymphokine-activated killer cells in rats. III. A simple method for the purification of large granular lymphocytes and their rapid expansion and conversion into lymphokine-activated killer cells.
  The Journal of Experimental Medicine, 1988
• Lymphokine-activated killer cell activity: Characteristics of effector cells and their progenitors in blood and spleen
  Immunology Today, 1987
• Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer
  New England Journal of Medicine, 1985